ISSN 2415-3060 (print), ISSN 2522-4972 (online)
  • 17 of 45
Up
JMBS 2023, 8(1): 133–139
https://doi.org/10.26693/jmbs08.01.133
Clinical Medicine

Changes in Left Ventricular Diastolic Function in Patients with Ischemic Heart Disease Depending on the Severity of Type 2 Diabetes Mellitus

Koshkina M. V.
Abstract

The purpose of the study was to determine the characteristics of changes in the diastolic function of the left ventricle in patients with coronary heart disease and type 2 diabetes mellitus of various degrees of severity. Materials and methods. The study included 106 patients with an average age of 68.8 ± 8.9 years (46.2% men (average age 65.2 ± 9.0 years) and 53.9% women (average age 71.6 ± 7.8 years)) with isolated coronary heart disease and in comorbidity with type 2 diabetes mellitus of various degrees of severity, which formed 4 research groups: the first group included 36 patients with a monocourse of coronary heart disease (average age 66.4 ± 10.1 years); the second group included 21 patients with coronary heart disease and mild type 2 diabetes mellitus (average age 71.9 ± 9.4 years); the third group – 28 people with coronary heart disease and type 2 diabetes mellitus of an average degree of severity (average age 69.7 ± 8.0 years) and the fourth group – 21 patients with coronary heart disease and type 2 diabetes mellitus with a severe course (average age 67.9 ± 6.5 years). All patients were receiving inpatient treatment in the cardiology department of the Communal Non-Profit Enterprise “City Clinical Hospital No. 27”. Results and discussion. The study showed that systolic blood pressure values are significantly higher in patients with coronary heart disease and moderate type 2 diabetes mellitus. In all groups of patients, the average values of both systolic and diastolic blood pressure were above normal values, which indicates the presence of hypertension. The average values of diastolic blood pressure increased with increasing severity of the course of type 2 diabetes mellitus. Regular reliable differences were found in the mean values of glucose metabolism indicators between groups. Also, triglyceridemia was reliably noted in patients with type 2 diabetes mellitus with a severe course. In the data of the patients, a predominance of very low-density lipoprotein cholesterol concentrations was also noted. The vast majority of lipid metabolism indicators were within the reference values, which may be due to the effect of hypolipidemic therapy. Conclusion. The analysis showed that the value of the time of isovolumetric relaxation of the left ventricle and the time of slowing down of the E peak, which is a strong indicator of the development of diastolic dysfunction, increase significantly with the increasing severity of type 2 diabetes mellitus. At the same time, the values of the ejection fraction in the research groups of patients did not differ significantly and were almost at the same level, which indicates the long-term preservation of the systolic function of the heart and the possible development against this background of isolated diastolic dysfunction in patients with concomitant coronary heart disease and type 2 diabetes mellitus

Keywords: ischemic heart disease, type 2 diabetes mellitus, degree of severity, diastolic dysfunction, lipid metabolism

Full text: PDF (Ukr) 281K

References
  1. Fatima T, Hashmi S, Iqbal A, Siddiqui AJ, Sami SA, Basir N, et al. Untargeted metabolomic analysis of coronary artery disease patients with diastolic dysfunction show disturbed oxidative pathway. Metabolomics. 2019 Jun 24;15(7):98. PMID: 31236740. https://doi.org/10.1007/s11306-019-1559-5
  2. Fan Y, Li Y, Chen Y, Zhao YJ, Liu LW, Li J, et al. Comprehensive Metabolomic Characterization of Coronary Artery Diseases. J Am Coll Cardiol. 2016 Sep 20;68(12):1281-93. PMID: 27634119. https://doi.org/10.1016/j.jacc.2016.06.044
  3. Patsouras A, Farmaki P, Garmpi A, Damaskos C, Garmpis N, Mantas D, et al. Screening and Risk Assessment of Coronary Artery Disease in Patients With Type 2 Diabetes: An Updated Review. In Vivo. 2019 Jul-Aug;33(4):1039-1049. PMID: 31280191. PMCID: PMC6689353. https://doi.org/10.21873/invivo.11572
  4. Naito R, Miyauchi K. Coronary Artery Disease and Type 2 Diabetes Mellitus. Int Heart J. 2017 Aug 3;58(4):475-480. PMID: 28717115. https://doi.org/10.1536/ihj.17-191
  5. Maiello M, Zito A, Carbonara S, Ciccone MM, Palmiero P. Left ventricular mass, geometry and function in diabetic patients affected by coronary artery disease. J Diabetes Complications. 2017 Oct;31(10):1533-1537. PMID: 28890308. https://doi.org/10.1016/j.jdiacomp.2017.06.014
  6. Cho DH, Kim MA, Choi J, Kim MN, Park SM, Kim HL, et al. Sex Differences in the Relationship Between Left Ventricular Diastolic Dysfunction and Coronary Artery Disease: From the Korean Women's Chest Pain Registry. J Womens Health (Larchmt). 2018 Jul;27(7):912-919. PMID: 29634453. https://doi.org/10.1089/jwh.2017.6610
  7. Tajima M, Nakayama A, Uewaki R, Mahara K, Isobe M, Nagayama M. Right ventricular dysfunction is associated with exercise intolerance and poor prognosis in ischemic heart disease. Heart Vessels. 2019 Mar;34(3):385-392. PMID: 30187119. https://doi.org/10.1007/s00380-018-1253-y
  8. Jia G, Whaley-Connell A, Sowers JR. Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease. Diabetologia. 2018 Jan;61(1):21-28. PMID: 28776083. PMCID: PMC5720913. https://doi.org/10.1007/s00125-017-4390-4
  9. Nakaz Ministerstva okhorony zdorov’ya Ukrainy 02.03.2016 № 152 (zi zminamy 23.09.2016 № 994). Unifikovanyi klinichnyi protokol pervynnoi, vtorynnoi (spetsializovanoi) ta tretynnoi (vysokospetsializovanoi) medychnoi dopomohy «Stabilna ishemichna khvoroba sertsya» [Unified clinical protocol of primary, secondary (specialized) and tertiary (highly specialized) medical care "Stable coronary heart disease"]. K; 2016. [Ukrainian]
  10. Nakaz Ministerstva okhorony zdorov’ya Ukrainy 21.12.2012 № 1118. Unifikovanyi klinichnyi protokol pervynnoi i vtorynnoi (spetsializovanoi) medychnoi dopomohy «Tsukrovyi diabet 2-ho typu» [Unified clinical protocol of primary and secondary (specialized) medical care "Type 2 diabetes mellitus"]. K; 2012. [Ukrainian]
  11. Ye X, Kong W, Zafar MI, Chen LL. Serum triglycerides as a risk factor for cardiovascular diseases in type 2 diabetes mellitus: a systematic review and meta-analysis of prospective studies. Cardiovasc Diabetol. 2019 Apr 15;18(1):48. PMID: 30987625. PMCID: PMC6466658. https://doi.org/10.1186/s12933-019-0851-z
  12. Mosenzon O, Alguwaihes A, Leon JLA, Bayram F, Darmon P, Davis TME, et al. CAPTURE: a multinational, cross-sectional study of cardiovascular disease prevalence in adults with type 2 diabetes across 13 countries. Cardiovasc Diabetol. 2021 Jul 27;20(1):154. PMID: 34315481. PMCID: PMC8317423. https://doi.org/10.1186/s12933-021-01344-0
  13. Vesa CM, Popa L, Popa AR, Rus M, Zaha AA, Bungau S, et al. Current Data Regarding the Relationship between Type 2 Diabetes Mellitus and Cardiovascular Risk Factors. Diagnostics (Basel). 2020 May 16;10(5):314. PMID: 32429441. PMCID: PMC7277953. https://doi.org/10.3390/diagnostics10050314
  14. Gupta R, Wood DA. Primary prevention of ischaemic heart disease: populations, individuals, and health professionals. Lancet. 2019 Aug 24;394(10199):685-696. PMID: 31448740. https://doi.org/10.1016/S0140-6736(19)31893-8